NRX Pharmaceuticals (NRXP) Earnings Date & Reports

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

NRXP is expected to report earnings to fall 602.00% to -5 cents per share on August 17

NRX Pharmaceuticals NRXP Stock Earnings Reports

Q2'26

Est.

$-0.05

Q4'25

Beat

by $0.53

Q3'25

Beat

by $0.25

Q2'25

Missed

by $0.45

Q1'25

Beat

by $0.19

The last earnings report on March 23 showed earnings per share of 0 cents, beating the estimate of -51 cents. With 1.34M shares outstanding, the current market capitalization sits at 185.54M.

View a ticker or compare two or three

Compare

NRXP

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for NRXP